Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Endostatins Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2018

1 Citations

A case report of advanced lung adenocarcinoma harboring KRAS mutation treated with anlotinib

Su, Y., Meng, Z., Xu, X., Wang, X., Zuo, R., Hou, Y., Li, K. & Chen, P., Jan 1 2018, In : Chinese Journal of Lung Cancer. 21, 5, p. 428-430 3 p.

Research output: Contribution to journalArticle

Mutation
Non-Small Cell Lung Carcinoma
Therapeutics
Platelet-Derived Growth Factor Receptors
Fibroblast Growth Factor Receptors
7 Citations

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: A multicentre, randomised phase II trial (ALTER0302)

Han, B., Li, K., Zhao, Y., Li, B., Cheng, Y., Zhou, J., Lu, Y., Shi, Y., Wang, Z., Jiang, L., Luo, Y., Zhang, Y., Huang, C., Li, Q. & Wu, G., Mar 6 2018, In : British journal of cancer. 118, 5, p. 654-661 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Confidence Intervals
Placebos
Disease-Free Survival
Therapeutics
1 Citations

Association between egfr/kras mutation and expression of vegfa, vegfr and vegfr2 in lung adenocarcinoma

Yuan, X. H., Yang, J., Wang, X. Y., Zhang, X. L., Qin, T. T. & Li, K., Aug 1 2018, In : Oncology Letters. 16, 2, p. 2105-2112 8 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Mutation
Exons
Vascular Endothelial Growth Factor Receptor-1
Adenocarcinoma of lung